The role of CD28 and CTLA4 in the function and homeostasis of CD4 +CD25+ regulatory T cells

Novartis Foundation Symposium

Volumn 252, Issue , 2003, Pages 55-66

  Boden, Elisa ^a   Tang, Qizhi ^a   Bour Jordan, Helene ^a   Bluestone, Jeffrey A ^a   Bach, ^b   Hafler, ^b   Banchereau, ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; DIFFERENTIATION ANTIGEN; INTERLEUKIN 2 RECEPTOR; LEUKOCYTE ANTIGEN;

ANIMAL; GENE DELETION; GENETICS; HOMEOSTASIS; HUMAN; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; MOUSE MUTANT; NUDE MOUSE; REVIEW; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD4; ANTIGENS, DIFFERENTIATION; DIABETES MELLITUS, TYPE 1; GENE DELETION; HOMEOSTASIS; HUMANS; MICE; MICE, KNOCKOUT; MICE, NUDE; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES;

EID: 2142649142     PISSN: None     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (29)

1. Alegre ML, Noel PJ, Eisfelder BJ et al 1996 Regulation of surface and intracellular expression of CTLA4 on mouse T cells. J Immunol 157:4762-4770
2. Asano M, Toda M, Sakaguchi N, Sakaguchi S 1996 Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med 184:387-396
3. Bachmann MF, Kohler G, Ecabert B, Mak TW, Kopf M 1999 Cutting edge: lymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous. J Immunol 163:1128-1131
4. + T cells with regulatory properties from human blood. J Exp Med 193:1303-1310
5. Hancock WW, Sayegh MH, Zheng XG, Peach R, Linsley PS, Turka LA 1996 Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection. Proc Natl Acad Sci USA 93:13967-13972
6. Herold KC, Hagopian W, Auger JA et al 2002 Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N Engl J Med 346:1692-1698
7. + T cells with regulatory properties isolated from peripheral blood. J Exp Med 193:1285-1294
8. Kappler JW, Roehm N, Marrack P 1987 T cell tolerance by clonal elimination in the thymus. Cell 49:273-280
9. Karandikar NJ, Vanderlugt CL, Walunas TL, Miller SD, Bluestone JA 1996 CTLA-4: a negative regulator of autoimmune disease. J Exp Med 184:783-788
10. Kisielow P, Bluthmann H, Staerz UD, Steinmetz M, von Boehmer H 1988 Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes. Nature 333:742-746
11. Lenschow DJ, Herold KC, Rhee L et al 1996 CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes. Immunity 5:285-293
12. Lepault F, Gagnerault MC 2000 Characterization of peripheral regulatory CD4+ T cells that prevent diabetes onset in nonobese diabetic mice. J Immunol 164:240-247
13. + T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med 193:1295-1302
14. Maxwell JR, Weinberg A, Prell RA, Vella AT 2000 Danger and OX40 receptor signaling synergize to enhance memory T cell survival by inhibiting peripheral deletion. J Immunol 164:107-112
15. + regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med 194:629-644
16. low CD4+ T cells: a population of T cells with immune regulatory activities in vitro. Eur J Immunol 28:3435-3447
17. + regulatory cells that control intestinal inflammation. J Exp Med 192:295-302
18. Rocha B, von Boehmer H 1991 Peripheral selection of the T cell repertoire. Science 251:1225-1228
19. Rogers PR, Song J, Gramaglia I, Killeen N, Croft M 2001 OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells. Immunity 15:445-455
20. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M 1995 Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155:1151-1164
21. Salomon B, Lenschow DJ, Rhee L et al 2000 B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12:431-440
22. + thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur J Immunol 31:1247-1254
23. + T cells: a highly differentiated and apoptosis-prone population. Eur J Immunol 31:1122-1131
24. Takahashi T, Kuniyasu Y, Toda M et al 1998 Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 10:1969-1980
25. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 192:303-310
26. Thornton AM, Shevach EM 1998 CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 188:287-296
27. Tivol EA, Borriello F, Schweitzer AN, Lynch WP, Bluestone JA, Sharpe AH 1995 Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3:541-547
28. Tivol EA, Boyd SD, McKeon S et al 1997 CTLA4Ig prevents lymphoproliferation and fatal multiorgan tissue destruction in CTLA-4-deficient mice. J Immunol 158:5091-5094
29. Waterhouse P, Penninger JM, Timms E et al 1995 Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 270:985-988